Activation of the iNOS/NO/cGMP pathway by Revactin® in human corporal smooth muscle cellsMónica G. Ferrini(Charles R. Drew University of Medicine and Science), Jacob Rajfer(University of California, Los Angeles)Translational Andrology and UrologyJune 24, 202110.21037/tau-21-11Cited by 3SaveCiteExport RISWatch citationsRelated PapersNutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway|PLoS ONE|2025|1